Carbapenem-resistant Klebsiella pneumoniae caused an outbreak in a hospital in Rome, Italy. The clinical isolates were tested by antimicrobial susceptibility testing, pulsed-field gel electrophoresis, multilocus sequence typing, plasmid typing, and ␤-lactamase identification. The OmpK35 and OmpK36 porins were analyzed by SDS-PAGE, and their genes were amplified and sequenced. Complementation experiments were performed using a recombinant unrelated ompK36 gene. An ertapenem-resistant and imipenem-and meropenem-susceptible clone was identified and assigned to the sequence type 37 lineage by MLST; it carried SHV-12 and CTX-M-15 ESBLs, did not produce the OmpK35 due to a nonsense mutation, and expressed a novel OmpK36 variant (OmpK36V). This variant showed two additional amino acids located within the L3 internal loop, one of the highly conserved domains of the protein. Two isolates of the same clone also exhibited resistance to imipenem and meropenem, due to the loss of OmpK36 expression by a nonsense mutation occurring in the ompK36V variant gene. These were the first carbapenem-resistant K. pneumoniae isolates identified within the hospital. Screening for the ompK36V gene of unrelated K. pneumoniae isolates derived from patients from 2006 to 2009 demonstrated the high frequency of this gene variant as well as its association with ertapenem resistance, reduced susceptibility to meropenem, and susceptibility to imipenem.
The susceptibility to carbapenems in the Enterobacteriaceae family is no longer guaranteed since the increasing occurrence of carbapenem-resistant isolates (26, 38) . Carbapenem resistance can arise by acquisition of resistance genes encoding metallo-␤-lactamases (MBLs) and non-metallo-carbapenemases (of the KPC, GES, or OXA type) but has also been associated with the AmpC cephalosporinase or extended-spectrum ␤-lactamase (ESBL) production and alterations of the expression of the major nonspecific porins. The latter mechanism has been reported worldwide in clinical isolates of Klebsiella pneumoniae, Escherichia coli, Enterobacter spp., and others (11, 12, 14-18, 23, 24, 31, 35) . The alteration of porin expression may be caused by several different events, including the disruption of the gene by insertion sequences, the termination of translation by nonsense mutations, and the downregulation of transcription by mutations occurring within the promoter (12, 18, 29) . In particular, the effect of the alteration of OmpK35 and OmpK36 expression in ESBL-producing K. pneumoniae isolates has been demonstrated to confer a high level of ertapenem resistance, with the MICs of imipenem and meropenem being raised (11, 12, 14, 16, 17, 24, 39) .
Sequence analysis of the ompK36 genes of clinical isolates of Enterobacter aerogenes, E. coli, and K. pneumoniae demonstrated the importance of transmembrane ␤-strand loop 3 (L3) in the specific uptake of ␤-lactams (3, 8, 36) . The L3 loop constitutes the channel eyelet of enterobacterial porins, extends inside the barrel, and constricts the pore (1) . The mutations occurring in L3 drastically change the channel properties, reducing the conductance of the channel and the uptake of carbapenems and cephalosporins (3, 8, 36) . In particular, the ertapenem has a net negative charge, its two carboxylic groups are able to form hydrogen bonds with the basic residues of the channel, and OmpK36 and OmpK35 represent the main pathway for the penetration of this drug into the bacterial periplasmic space (17, 19) .
In the present study, two carbapenem-resistant K. pneumoniae strains producing ESBL and lacking the OmpK35 and OmpK36 porins were derived from a colonized patient at the University Hospital Policlinico Umberto I in Rome, Italy. K. pneumoniae clonal isolates showing ertapenem resistance and increased MICs of meropenem but susceptibility to imipenem were also isolated from the same patient. These strains lacked the OmpK35 porin but produced normal levels of the OmpK36 porin and were further characterized, revealing a particular OmpK36 porin variant. This porin variant was found to be widely distributed in unrelated K. pneumoniae strains within the hospital, and in association with ESBL production and the OmpK35 depletion, the variation conferred a characteristic ertapenem-resistant (ETP r ) phenotype which is different from that observed for carbapenem-resistant strains lacking both the OmpK35 and OmpK36 porins.
MATERIALS AND METHODS
Strains and antimicrobial susceptibility testing. The K. pneumoniae strains analyzed in this study were isolated and identified at the Microbiology Laboratory of the Policlinico Umberto I Hospital in Rome by routine procedures.
Antimicrobial susceptibility was determined by the Vitek 2 system with the AST-N089 card (bioMérieux, Marcy l'Etoile, France). The MICs of piperacillintazobactam (TZP), aztreonam (ATM), cefoxitin (FOX), cefotaxime (CTX), cefepime (FEP), ceftazidime (CAZ), imipenem (IPM), and meropenem (MEM) were determined by Etest on Mueller-Hinton agar II (bioMèrieux, Marcy l'Etoile, France). The MICs of ETP were determined by a microdilution technique in Mueller-Hinton broth (7) . ESBL production was confirmed by cefotaxime/cefotaxime-clavulanic acid (CT/CTL) ESBL strips (AB bioMèrieux, Solna, Sweden) on Mueller-Hinton agar II. Breakpoints and MICs were interpreted in accordance with the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines.
Screening tests for ␤-lactamases and ESBL gene identification. ␤-Lactamase extracts were obtained by ultrasonic treatment of bacterial cells suspended in phosphate buffer (0.1 M, pH 7.0) and clarified by centrifugation. Analytical isoelectric focusing (IEF) was performed in polyacrylamide gels containing ampholytes (pH range, 3.5 to 9.5; APBiotech, Piscataway, NJ). ␤-Lactamases were detected with nitrocefin (0.2 mg/ml; Oxoid Ltd., Basingstoke, United Kingdom). Detection of carbapenemase activity in the cell-free ␤-lactamase extracts was performed by a bioassay, as described previously (42) , by using E. coli DH5␣ (Invitrogen, Milan, Italy) as a susceptible indicator strain and imipenem (10-g) and meropenem (10-g) discs (Oxoid Ltd.).
PCR amplification for detection of the bla CTX-M , bla SHV , bla TEM, bla OXA (including bla OXA-48 ), bla KPC, bla GES , and ampC genes was carried out as described previously (2, 6, 28, 32-34, 40, 41) . The PCR products were purified by a Wizard PCR preps DNA purification system (Promega, Madison, WI), sequenced, and analyzed at the http://www.ncbi.nlm.nih.gov website by the Basic Local Alignment Search Tool (BLAST) program.
Plasmid localization of ESBL genes. Plasmid DNA was purified with a plasmid midikit (Qiagen Inc., Milan, Italy), separated by 0.8% agarose gel electrophoresis, and blotted onto a positively charged nylon membrane (Roche Diagnostics, Monza, Italy) by standard procedures. Filters were hybridized with digoxigeninlabeled (PCR DIG probe synthesis kit; Roche Diagnostics GmbH, Mannheim, Germany) repF, bla CTX-M-15 , and bla SHV amplicons, obtained with primers described previously (2, 5, 6) .
Plasmids were transferred by transformation (MAX Efficiency DH5␣ chemically competent E. coli cells; Invitrogen) and conjugation (the rifampin-resistant E. coli CSH26 was used as the recipient strain). Selection of the transformants and transconjugants was performed on LB agar plates containing ampicillin (100 g/ml) and ampicillin plus rifampin (100 g/ml) (Sigma-Aldrich Chemie GmbH, Steinheim, Germany), respectively. Plasmids were typed by the PCR-based replicon typing method (PBRT), as described previously (5) .
Clone genotyping by PFGE and MLST. The genetic relatedness of the isolates was assessed by pulsed-field gel electrophoresis (PFGE) analysis of XbaI-digested genomic DNA, as described previously (37) . Electrophoresis was for 30 h at 14°C with pulse times ranging from 5 to 35 s at 6 V/cm. Multilocus sequence typing (MLST) was carried out with the rpoB, gapA, mdh, pgi, phoE, infB, and tonB genes, as described previously (10) . Sequence types (STs) were assigned at the http://www.pasteur.fr/recherche/genopole/PF8/mlst/ website. Examination of porins. Outer membrane protein (OMP) preparations were obtained after sonication of bacterial cells grown in Mueller-Hinton broth, followed by selective solubilization of the cytoplasmic material with sodium Nlauroyl sarcosinate (2% wt/vol) and ultracentrifugation (30) . The preparations were run on discontinuous SDS-polyacrylamide gels (12.0%) and stained with Coomassie blue. The coding sequences of the ompK36 and ompK35 genes from K. pneumoniae were amplified and sequenced using previously described primers (21, 31) .
Restoration of OmpK36. Plasmid pSHA2, encoding a wild-type OmpK36 protein (30) , was introduced into the K. pneumoniae cells by electroporation, and transformants were selected on LB agar plates containing ampicillin (50 g/ml) and potassium tellurite (30 g/ml) (Sigma-Aldrich Chemie GmbH). Expression of the cloned porin was analyzed by SDS-PAGE. The MICs for the transformants were measured as described above.
Amplification of the ompk36V gene variant. Primers ompK36V Fw (5Ј-ATG AAAGTTAAAGTACTGTC-3Ј) and ompK36V Rv (5Ј-CGTAGGTGTCGGTG TC-3Ј) were designed to detect strains carrying the ompK36V gene.
DNA sequencing. Amplicons were sequenced by the fluorescent dye-labeled dideoxynucleotide method with an ABI 3730 automatic DNA sequencer (PerkinElmer, Foster City, CA). The sequences from multiple PCR products were determined in both directions.
Nucleotide sequence accession numbers. The nucleotide sequences of the ompK35 and ompK36 genes were released under EMBL accession nos. GU460159, GU460160, GU460161, and GU460162 and nos. GQ433376 and GQ433377, respectively.
RESULTS AND DISCUSSION
Case description. On 13 May 2008, a 74-year-old man (patient A) was admitted to the University Hospital Policlinico Umberto I in Rome for ischemic heart disease. On day 10 after hospital admission, he underwent placement of an aortic-coronary bypass. During the postsurgery period, he required tracheostomy and prolonged mechanical ventilator support. His clinical course was also complicated by acute renal insufficiency requiring continuous renal replacement therapy. On 9 June, he underwent reconstructive surgical closure of a dehiscent sternal wound with pectoral muscle flaps. On 15 July, a second dehiscence on the sternal wound with coinfection by Staphylococcus epidermidis and Enterococcus faecalis required reconstructive surgery and treatment with piperacillin-tazobactam (2.25 g intravenously every 6 h for 3 days) plus linezolid (600 mg intravenously every 12 h for 21 days). On 3 September, the patient developed a sepsis syndrome with acute renal insufficiency due to Pseudomonas aeruginosa mediastinitis. After surgical debridement, a 4-week course of treatment with meropenem (1 g intravenously every 8 h) was administered and cured the infection. On the following days, the patient required additional antibiotic treatment with meropenem (1 g intravenously every 8 h) due to recurrent ventilator-associated respiratory tract infections caused by a multiple-antibiotic-resistant P. aeruginosa strain and sternal wound infections from which P. aeruginosa and ESBL-producing and carbapenem-susceptible strains of E. coli and K. pneumoniae (strain 16855) were isolated on 30 October. On 3 November an ETP r and meropenem-and imipenem-susceptible K. pneumoniae strain (strain 17049) was isolated from a sacral ulcer wound swab. On 13 and 19 November, two carbapenem-resistant (CBP r ) K. pneumoniae strains (strains 17829 and 18260) were isolated from the sacral ulcer and rectal swab, respectively. Additional ETP r K. pneumoniae strains were isolated from tracheal/bronchial aspirates (strains 18567 and 19039) and rectal swabs (strain 18918), until the patient's death on 10 December 2008 due to central venous catheter bacteremia caused by P. aeruginosa infection. Except for strain 16855, none of the other K. pneumoniae isolates were considered pathogens. K. pneumoniae did not appear to be involved in the final fatal outcome in this patient.
Identification of outbreak clone. The seven K. pneumoniae strains isolated from patient A were genotyped along with two additional ETP r strains (strains 17830 and 17834) isolated on the same day that strain 17829 was but from patients B and C, respectively; and these were probably the three patients involved in an outbreak that occurred within the hospital (Table 1) .
All but one of the isolates showed indistinguishable PFGE patterns, suggesting the presence of an epidemic clone circulating within the cardiac surgery intensive care unit and the general surgery ward (data not shown). Carbapenem-susceptible strain 16855, the first K. pneumoniae strain isolated from patient A, showed a different PFGE pattern.
MLST identified the outbreak clone as being of ST37. The only CBP r K. pneumoniae strain belonging to the ST37 lineage previously detected was isolated in the United States in 1996 and carries the KPC-2 ␤-lactamase (22 and 17834 (patient C). These strains were negative for carbapenemase activity (data not shown); but all of them produced TEM-1, SHV-11, and CTX-M-15 (pIs 5.4, 7.6, and 8.9, respectively). Strains 17829 and 17830 also produced the SHV-12 ␤-lactamase (pI 8.2), and strains 17830 and 17834 produced the OXA-1 ␤-lactamase (pI 7.4) ( Table 2 ). All the bla genes except bla SHV-11 , which is likely the naturally occurring bla SHV gene located within the chromosome of K. pneumoniae (25) , were identified on plasmids, as shown by transformation and conjugation experiments. The strains were positive for IncFII plasmids carrying different combinations of ␤-lactamase genes ( Table 2 ). For instance, strain 17829 transferred the bla TEM-1 , bla , and bla CTX-M-15 genes on the same plasmid, while two different plasmids were obtained from strain 17830, one self-conjugative plasmid carrying the bla OXA-1 and bla CTX-M-15 genes and one plasmid untypeable by PBRT carrying the bla TEM-1 and bla SHV-12 genes. These data may indicate a plasmid fusion/resolution event within strain 17829 generating a single plasmid of the IncFII group carrying the two ESBL genes and bla TEM-1 but lacking the bla OXA-1 gene. The colocalization of the bla SHV-12 and bla CTX-M-15 genes within a large EcoRI band (Ͼ20 kb) was confirmed by hybridizations performed with the 17829 donor and transformant strains; this band was also positive for the repFII replicon (Fig. 1) . The emergence and spread of the CTX-M-15 enzyme are described worldwide (27) . The bla CTX-M-15 gene has been located on IncFII plasmids, often in association with bla TEM-1 and bla OXA-1 resistance genes; but this is the first report of the colocalization of the bla TEM-1 , bla , and bla CTX-M-15 genes on this plasmid type (4). This plasmid may favor the simultaneous spread of these resistance genes.
Carbapenem susceptibility and OmpK35 and OmpK36 porins. Of the eight outbreak strains from patients A, B, and C, six strains showed ertapenem MICs ranging from 6 to 8 g/ml, imipenem MICs ranging from 0.19 to 0.25 g/ml, and meropenem MICs ranging from 0.75 to 2 g/ml. Strains 17829 and 18260 showed ertapenem MICs of 128 g/ml, imipenem MICs of 12 g/ml, and meropenem MICs of 12 g/ml. The last three strains were the first two CBP r K. pneumoniae strains identified at the hospital. Susceptible strain 16855 showed an ertapenem MIC of 0.094 g/ml, an imipenem MIC of 0.25 g/ml, and a meropenem MIC of 0.064 g/ml ( Table 1 ). The clonal (Fig. 2) . The ompK35 and ompK36 genes were amplified and sequenced. In all these strains, the sequence of ompK35 showed an A 3 T mutation at codon 36, generating a TAA nonsense mutation, resulting in the termination of translation (EMBL accession no. GU460159). Sequencing of the ompK36 genes from the ETP r strains revealed a novel OmpK36 protein variant (designated OmpK36V and indicated 36V in Table 1) showing 94% to 99% amino acid identities with other K. pneumoniae OmpK36 proteins (EMBL accession nos. Q48473, FJ577673, CAC50885, and ABR78053). In particular, in the deduced protein sequence we noted the insertion of two additional amino acids, Asp137 and Thr138, located in one of the most conserved sites of the protein among enterobacterial and nonenterobacterial porins, the so-called PEFXG motif (1, 13, 20) . This alteration was generated by the insertion of six nucleotides (5Ј-GACACC-3Ј) at nucleotide (nt) positions 454 to 459 (EMBL accession no. GQ433376), apparently due to the duplication of the adjacent region (nt positions 448 to 453) encoding the Asp135 and Thr136 codons. Subsequent to the duplication, the Asp135-Thr136-Asp137-Thr138 motif was generated. This motif flanked the PEFXG domain (codons 130 to 134) within the L3 loop (Fig. 3A) . To our knowledge, this is the first description of a naturally occurring amino acid insertion within the L3 of OmpC-related enterobacterial proteins, and such a change has not been generated in functional studies of the porin structure. However, amino acid substitutions occurring in other key residues of L3 have been demonstrated to alter the pore properties, and, for instance, the replacement of a Gly112 with a charged-side-chain residue (Asp) resulted in changes of the pore properties and resistance to cephalosporins in E. aerogenes (Fig. 3A) (3, 8, 9, 36) . The effect of the duplication of the Asp-Thr residues may therefore play an important role in the permeability of K. pneumoniae cells, thus contributing to ertapenem resistance and reduced susceptibility to meropenem. The two CBP r strains (strains 17829 and 18260) carried the ompK36V gene variant, but an additional G 3 A mutation at codon 125 generated a TAG premature stop codon, resulting in the termination of OmpK36 translation (EMBL accession no. GQ433377; Fig. 3A) .
Complementation studies. To elucidate the contribution of OmpK36 to carbapenem resistance in the ST37 K. pneumoniae clone, strains 17829, 18260, 17830, and 17049 were transformed with plasmid pSHA2 carrying an ompK36 wildtype gene and the tellurite resistance marker (30) . Stable tellurite-resistant transformants, namely, those lacking OmpK36, were obtained for strains 17829 and 18260, while the other two strains produced few transformants and were highly unstable and unviable. The transformants expressed very low levels of the recombinant protein (Fig. 2) . However, the introduction of a functional OmpK36 porin restored the susceptibility to imipenem (MIC ϭ 1 g/ml) and meropenem (MIC ϭ 1 g/ml) and greatly reduced the MICs of ertapenem (MIC ϭ 16 g/ml) ( Table 1) .
Screening of the unrelated K. pneumoniae isolates carrying OmpK36V. Fifteen unrelated K. pneumoniae strains isolated from different patients and from different wards at the Hospital Policlinico Umberto I from 2006 to 2009 were selected from among a collection of 129 nonconsecutive isolates showing different MICs of cephalosporins and carbapenems (Table 1) . In particular, 13 strains were ESBL positive; 7 of them were also ETP r , showing MICs ranging from 4 to 16 g/ml; and 2 showed ␤-lactam-susceptible phenotypes. A PCR-based test was set up to positively amplify the 6-nucleotide insertion in the ompK36V gene, and this variant gene was identified in six of the seven ETP r strains (designated 36V in Table 1 ). These strains also showed increased MICs of meropenem (MIC range, 1 to 1.5 g/ml) but were susceptible to imipenem (MIC range, 0.19 to 0.5 g/ml). The unique ETP r strain which was negative by the OmpK36V PCR (strain 25008) showed a different phenotype, being resistant to meropenem (MIC ϭ 4 g/ml) and showing an increased MIC of imipenem (MIC ϭ 1 g/ml). All the ertapenem-susceptible strains were negative for OmpK36V amplification (Table 1) .
The 15 selected strains were further characterized by ompK36 and ompK35 gene sequencing and analysis of porin expression by SDS-PAGE (Fig. 2) . Thirteen strains did not produce the OmpK35 porin due to nonsense mutations occurring in the ompK35 gene: seven strains showed a stop codon at position 36, namely, the same sequence observed in the ST37 clonal strains (EMBL accession no. GU460159), and five strains and one strain showed a stop codon at positions 63 and 75, respectively (EMBL accession nos. GU460160 and GU460161, respectively; Fig. 3B ). Two strains showed a wild-type ompK35 gene, but strain 31750 did not produce the protein, possibly due to mutations occurring in the promoter (EMBL accession no. GU460162; Fig. 2 ). Strain 25008 did not produce either OmpK35 or OmpK36 and did not amplify the ompK36 gene (Table 1 ; Fig. 2 ). The presence of the variant ompK36V in PCR-positive strains was confirmed by DNA sequencing of the ompK36 gene. All these strains expressed OmpK36V but did not express the OmpK35 because of the nonsense mutation at codon 36 (Fig. 3B) . The MLST analysis performed with these strains demonstrated that they belonged to the ST37 clone, while strains showing different ompK36 and ompK35 genes did not (data not shown). Interestingly, the earliest isolate of our collection, strain 50748, isolated in 2006, also belonged to ST37 and showed the nonsense mutation at codon 36 in OmpK35 but carried a wild-type OmpK36 porin. This strain produced the CTX-M-15, SHV-11, and TEM-1 ␤-lactamases (data not shown) and was susceptible to the three carbapenems tested ( Table 1) . The results obtained suggested that the depletion of OmpK35 and the production of a wild-type OmpK36 did not associate with a significant increase in the MICs of carbapenems in ESBL-producing strains (strains 50748, 31750, 11932, 16830, 287942, and 29459 in Table 1 ). An additional mutational event leading to the production of OmpK36V correlated, in ESBL-producing strains, with ertapenem resistance and increased MICs of meropenem (strains 17049, 17830, 17834, 18567, 18918, 19039, 69036, 69928, 71697, 6267, 26077, and 29830 in Table 1 ). High levels of resistance to carbapenems were observed in the ESBL-producing strains that did not produce either the OmpK35 or the OmpK36 porin (strains 17829, 18260, and 25008 in Table 1) .
Concluding remarks. A K. pneumoniae ST37 clone producing CTX-M-15 and wild-type OmpK36 but lacking OmpK35 because of a nonsense mutation has likely circulated in our hospital since 2006. This clone carrying the bla CTX-M-15 gene located on the IncFII plasmid might have evolved by a 6-nucleotide duplication in the ompK36 gene, generating the OmpK36V variant, which was identified in strains from patients in the hospital since 2007. Strains carrying this variant showed increased MICs of several ␤-lactams, including cefoxitin, cefepime, and meropenem, and were resistant to ertapenem. More recently, in patient A, this clone evolved by acquisition of a nonsense mutation causing the termination of translation of the gene for OmpK36V, conferring resistance to all carbapenems. Patient A probably acted as a reservoir of this clone, since several strains were isolated from the sacral ulcer and rectal swabs and the carbapenem-resistant variants were likely positively selected by the treatment of the patient with meropenem. We can hypothesize that the presence of the OmpK36V conferring an increased MIC of meropenem could have favored the survival of the bacteria under meropenem treatment, allowing the emergence of the fully carbapenemresistant strains.
With the increasing use of carbapenems that are specifically designed to resist degradation by bacterial enzymes, the pathogen is forced to adopt novel strategies to restrict the intracellular antibiotic concentration. The OmpK36V porin mutation detected in this study may represent just an example of bacterial selection under the pressure of antibiotic treatment. Ertapenem-resistant strains have been described to be hidden within populations of susceptible bacteria, appearing as a subpopulation at a frequency of 10 Ϫ6 only under the positive selection exerted by the ertapenem administration or direct selection on culture media (24) .
The presence of mutations altering the properties of the OmpK36 porin might be underestimated by standard analysis. It is also important to point out that loss or modification of the porins must be associated with the production of AmpC or ESBLs to confer carbapenem resistance. Consequently, multifactorial events are required to establish the carbapenem resistance phenotype in enterobacterial pathogens. However, once these events take place, the positive selection imposed by the extensive use of antimicrobials may favor the expansion of resistant clones, promoting their diffusion within the hospital.
